Corner Therapeutics Research Opens Door to Universal Flu Vaccine and Expands Promise for Cancer Immunotherapy Corner Therapeutics, a biotechnology company specializing in in vivo T cell modulation and immunotherapy, has…
Alnylam Pharmaceuticals Launches $500 Million Convertible Senior Notes Offering to Strengthen Strategic Flexibility and Advance RNAi Pipeline Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the biotechnology pioneer recognized worldwide as the leader…
JCR Pharmaceuticals Showcases Landmark Five-Year Clinical Data on Pabinafusp Alfa at ICIEM 2025, Reinforcing Transformative Potential for Patients with Hunter Syndrome and Expanding Pipeline of Brain-Penetrant Enzyme Replacement Therapies In…
Cellworks Unveils Breakthrough in Predicting Chemo-Immunotherapy Benefit for Patients with Metastatic NSCLC Cellworks Group Inc., a leader in personalized therapy decision support and best-in-class patient-specific treatment response simulations (PTRS), has…
Tolerance Bio and ZipCode Bio Forge Strategic R&D Collaboration to Advance Targeted Thymus Therapeutics In a landmark move that underscores the growing intersection of immunology and RNA-based medicine, Tolerance Bio,…
GE HealthCare and CDL Nuclear Technologies Partner to Expand Access to Flyrcado™, a Novel Cardiac PET Imaging Agent, Across the United States GE HealthCare (Nasdaq: GEHC) has announced a pivotal…
Amazon Pharmacy Expands $5 RxPass Subscription Service to Texas, Offering Affordable Medication Access for Millions Amazon Pharmacy, the digital healthcare arm of Amazon, announced today that it is expanding RxPass,…
FDA Expands Approval of Takeda’s VONVENDI®, First Recombinant von Willebrand Factor Therapy, to Include Routine Prophylaxis for Adults and Children with von Willebrand Disease Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), a…
Aptar Pharma and Dianosic Forge Exclusive Partnership to Advance Resorbable Intranasal Scaffold Technology for Chronic Rhinitis, Sinusitis, and Beyond In a strategic move that underscores the growing importance of patient-centric…
Nature Medicine Publishes Phase 3 Data on Pridopidine, Offering Hope in Early-Stage Huntington’s Disease Prilenia Therapeutics B.V., a clinical-stage biopharmaceutical company specializing in neurodegenerative diseases, together with its partner Ferrer,…
Genentech Presents New Long-Term Data for Vabysmo in Wet AMD and PCV at Euretina Congress 2025 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced…
WHO Expands Essential Medicines Lists to Include Landmark Treatments for Cancer, Diabetes, and Other Major Disease The World Health Organization (WHO) has announced a major update to its Model Lists…